S&P 500
(0.36%) 5 118.27 points
Dow Jones
(0.31%) 38 357 points
Nasdaq
(0.41%) 15 993 points
Oil
(-0.79%) $83.19
Gas
(5.51%) $2.03
Gold
(0.44%) $2 357.60
Silver
(0.51%) $27.68
Platinum
(3.99%) $958.85
USD/EUR
(-0.26%) $0.932
USD/NOK
(-0.41%) $10.98
USD/GBP
(-0.59%) $0.796
USD/RUB
(1.66%) $93.40

实时更新: Savara Inc [SVRA]

交易所: NASDAQ 部门: Healthcare 工业: Biotechnology
BUY
85.71%
return 7.99%
SELL
42.86%
return 2.64%
最后更新时间30 Apr 2024 @ 00:32

5.33% $ 4.65

购买 107971 min ago

@ $4.95

发出时间: 15 Feb 2024 @ 01:02


回报率: -6.07%


上一信号: Feb 14 - 22:33


上一信号: 出售


回报率: 0.30 %

Live Chart Being Loaded With Signals

Commentary (30 Apr 2024 @ 00:32):

Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis...

Stats
今日成交量 230 682
平均成交量 849 300
市值 641.70M
EPS $0 ( 2024-03-28 )
下一个收益日期 ( $-0.100 ) 2024-05-20
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -14.08
ATR14 $0.00500 (0.11%)
Insider Trading
Date Person Action Amount type
2024-04-21 Erickson Anne Sell 381 Common Stock
2024-03-21 Erickson Anne Sell 0 Common Stock
2024-03-21 Erickson Anne Sell 2 000 Stock Option (Right to Buy)
2024-03-21 Erickson Anne Sell 25 000 Stock Option (Right to Buy)
2024-03-21 Erickson Anne Sell 75 000 Stock Option (Right to Buy)
INSIDER POWER
70.24
Last 97 transactions
Buy: 7 951 114 | Sell: 857 126

音量 相关性

長: -0.12 (neutral)
短: 0.79 (moderate)
Signal:(67.01) Neutral

Savara Inc 相关性

10 最正相关
NVCN0.962
OVID0.956
HCCI0.956
PUCK0.95
KVSA0.949
GXII0.948
ADER0.948
VBOC0.947
UBFO0.947
TWLV0.945
10 最负相关
AMGN-0.957
AHPI-0.954
NAKD-0.938
STAB-0.937
CYTO-0.931
PROC-0.922
TUEM-0.917
ORPH-0.917
HCAQ-0.913
LSAQ-0.91

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Savara Inc 相关性 - 货币/商品

The country flag -0.58
( weak negative )
The country flag -0.62
( weak negative )
The country flag 0.00
( neutral )
The country flag -0.37
( neutral )
The country flag 0.70
( moderate )
The country flag -0.47
( neutral )

Savara Inc 财务报表

Annual 2023
营收: $0
毛利润: $-175 000 (0.00 %)
EPS: $-0.330
FY 2023
营收: $0
毛利润: $-175 000 (0.00 %)
EPS: $-0.330
FY 2022
营收: $0
毛利润: $-167 000 (0.00 %)
EPS: $-0.250
FY 2021
营收: $0.00
毛利润: $-136 000 (0.00 %)
EPS: $-0.725

Financial Reports:

No articles found.

Savara Inc

Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。